AAAAAA

   
Results: 1-7 |
Results: 7
APOLIPOPROTEIN-E EPSILON-4 ALLELE AS A GENETIC RISK FACTOR FOR LEFT-VENTRICULAR FAILURE IN HOMOZYGOUS BETA-THALASSEMIA
Authors: ECONOMOUPETERSEN E AESSOPOS A KLADI A FLEVARI P KARABATSOS F FRAGODIMITRI C NICOLAIDIS P VRETTOU H VASSILOPOULOS D KARAGIORGALAGANA M KREMASTINOS DT PETERSEN MB
Citation: E. Economoupetersen et al., APOLIPOPROTEIN-E EPSILON-4 ALLELE AS A GENETIC RISK FACTOR FOR LEFT-VENTRICULAR FAILURE IN HOMOZYGOUS BETA-THALASSEMIA, Blood, 92(9), 1998, pp. 3455-3459
G GBV-C INFECTION IN THE GENERAL-POPULATION AND IN HIGH-RISK GROUPS OF A EUROPEAN COUNTRY/
Authors: HADZIYANNIS SJ SPANOU E HADZIYANNIS AS TRIANTAFILLIDIS E VRETTOU H PAPAKONSTANTINOU A GIOUSTOZI A
Citation: Sj. Hadziyannis et al., G GBV-C INFECTION IN THE GENERAL-POPULATION AND IN HIGH-RISK GROUPS OF A EUROPEAN COUNTRY/, Hepatology, 26(4), 1997, pp. 790-790
HUMAN RECOMBINANT ERYTHROPOIETIN USED ALO NE AND IN COMBINATION WITH HYDROXYUREA IN THALASSEMIA-INTERMEDIA AND SICKLE-CELL DISEASE PATIENTS
Authors: POLITIS C FRAGATOU S VRETTOU H HATZILAOU J TZIOKA A MIARITI N XANTHAKI A BASSAYIANNIS A
Citation: C. Politis et al., HUMAN RECOMBINANT ERYTHROPOIETIN USED ALO NE AND IN COMBINATION WITH HYDROXYUREA IN THALASSEMIA-INTERMEDIA AND SICKLE-CELL DISEASE PATIENTS, Gematologia i transfuziologia, 42(1), 1997, pp. 15-16
FREQUENCY AND CLINICAL CORRELATES OF DUAL INFECTIONS WITH THE HEPATITIS-G AND HEPATITIS-C VIRUSES
Authors: HADZIYANNIS SJ PAPAKONSTANTINOU A VRETTOU H SPANOU F ZACHARAKIS G LARAS A
Citation: Sj. Hadziyannis et al., FREQUENCY AND CLINICAL CORRELATES OF DUAL INFECTIONS WITH THE HEPATITIS-G AND HEPATITIS-C VIRUSES, Hepatology, 24(4), 1996, pp. 410-410
INTERFERON-ALPHA-2B TREATMENT OF CHRONIC HEPATITIS-C IN HEMODIALYSIS-PATIENTS
Authors: RAPTOPOULOUGIGI M SPAIA S GARIFALLOS A XENOU P ORPHANOU H ZARAFIDOU E PETRIDOU P VRETTOU H VAGIONAS G GALAKTIDOU G MAVROUDI I EFKARPIDOU A KORTSARIS A
Citation: M. Raptopoulougigi et al., INTERFERON-ALPHA-2B TREATMENT OF CHRONIC HEPATITIS-C IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1834-1837
THE PREVALENCE OF A NEW HEPATITIS-VIRUS (HGV) IN PATIENTS WITH LIVER-DISEASE AND IN GROUPS AT HIGH-RISK OF EXPOSURE TO BLOOD AND BLOOD PRODUCTS
Authors: HESS G HORSCH A HADZIYANNIS S VRETTOU H WAGES J PIATAK M KIM JP FOUNG S KARAYINNIS P THOMAS HC
Citation: G. Hess et al., THE PREVALENCE OF A NEW HEPATITIS-VIRUS (HGV) IN PATIENTS WITH LIVER-DISEASE AND IN GROUPS AT HIGH-RISK OF EXPOSURE TO BLOOD AND BLOOD PRODUCTS, Transfusion, 35(10), 1995, pp. 224-224
INTERFERON TREATMENT OF CHRONIC ACTIVE HEPATITIS-B - EFFECT OF A 6-MONTH TREATMENT REGIMEN
Authors: RAPTOPOULOU M ORPHANOU H VRETTOU H AKRIBIADIS E CHADZIKONSTANTINOU L GOULIS G
Citation: M. Raptopoulou et al., INTERFERON TREATMENT OF CHRONIC ACTIVE HEPATITIS-B - EFFECT OF A 6-MONTH TREATMENT REGIMEN, Gut, 34(2), 1993, pp. 102-103
Risultati: 1-7 |